ZEPATIER
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
0006-3074 -
Package NDC
0006-3074-02 -
Application number
NDA208261 -
SPL ID
227ae348-5f6f-44d8-a6dc-103e63d28102 -
SPL set ID
164dc02a-9180-426a-b8b5-04ab39d2bbd4 -
UNII
632L571YDK -
UNII
8YE81R1X1J -
RxCUI
1734636 -
RxCUI
1734642
What the source publishes
- Labeler
- Merck Sharp & Dohme LLC
- Active ingredients
- elbasvir and grazoprevir
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "ZEPATIER",
"splId": "227ae348-5f6f-44d8-a6dc-103e63d28102",
"labels": [
{
"setId": "164dc02a-9180-426a-b8b5-04ab39d2bbd4",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=164dc02a-9180-426a-b8b5-04ab39d2bbd4",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=164dc02a-9180-426a-b8b5-04ab39d2bbd4"
}
],
"routes": [
"ORAL"
],
"labeler": "Merck Sharp & Dohme LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "2 DOSE PACK in 1 CARTON (0006-3074-02) / 14 TABLET, FILM COATED in 1 DOSE PACK (0006-3074-01)",
"package_ndc": "0006-3074-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20160128"
}
],
"productId": "0006-3074_227ae348-5f6f-44d8-a6dc-103e63d28102",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "0006-3074",
"deaSchedule": null,
"genericName": "elbasvir and grazoprevir",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ELBASVIR",
"strength": "50 mg/1"
},
{
"name": "GRAZOPREVIR ANHYDROUS",
"strength": "100 mg/1"
}
],
"applicationNumber": "NDA208261",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20160128",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000191256",
"N0000190113",
"N0000182638",
"N0000182639",
"N0000190114"
],
"unii": [
"632L571YDK",
"8YE81R1X1J"
],
"rxcui": [
"1734636",
"1734642"
],
"spl_set_id": [
"164dc02a-9180-426a-b8b5-04ab39d2bbd4"
],
"pharm_class_epc": [
"Hepatitis C Virus NS5A Inhibitor [EPC]",
"Hepatitis C Virus NS3/4A Protease Inhibitor [EPC]"
],
"pharm_class_moa": [
"Breast Cancer Resistance Protein Inhibitors [MoA]",
"HCV NS3/4A Protease Inhibitors [MoA]",
"Cytochrome P450 3A Inhibitors [MoA]"
],
"manufacturer_name": [
"Merck Sharp & Dohme LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:0006-3074_227ae348-5f6f-44d8-a6dc-103e63d28102"